论文信息 - Phase II multicenter study of chemotherapy (chemo)-naive castration-resistant prostate cancer (CRPC) not exposed to ketoconazole (keto), treated with abiraterone acetate (AA) plus prednisone. - 字舞流文

Phase II multicenter study of chemotherapy (chemo)-naive castration-resistant prostate cancer (CRPC) not exposed to ketoconazole (keto), treated with abiraterone acetate (AA) plus prednisone.

E. Small | G. Bubley | C. Logothetis | M. Taplin | E. Efstathiou | C. Ryan | C. Haqq | A. Molina | T. Kheoh | M. Smith | M. Smith | G. Bubley